Back

Disabling Muller Glia Preserves Retinal Function After Retinal Injury

Larbi, D.; Chen, S.; Indictor, A.; Gibbons, L. D.; Kang, S.; Rief, A. M.; Wohl, S. G.

2026-04-16 neuroscience
10.64898/2026.04.14.718211 bioRxiv
Show abstract

We developed a physiologically relevant light damage model in pigmented mice and determine how Muller glial (MG) Dicer1/microRNA (miRNA) loss impacts retinal structure and function after injury. A moderate light damage paradigm (5,000 lux, 4 hours) was developed in pigmented mice carrying the RPE65 Leu450 variant. MG-specific Dicer1 conditional knockout (cKO) mice across three Cre lines (Rlbp1-CreER, Glast-CreER, Ascl1-CreER) were subjected to light damage at different developmental stages. Retinal structure and function were assessed longitudinally using optical coherence tomography (OCT), histology, and electroretinography (ERG). Preconditioning and double-damage paradigms were included as controls. The model induced progressive photoreceptor degeneration with early functional decline preceding structural loss and delayed inner retinal impairment. Across all MG-specific Dicer1-cKO lines, retinas exhibited partial structural preservation and, more prominently, sustained functional preservation following injury. Inner retinal function (Vmax) was consistently maintained despite reduced photoreceptor input. This phenotype was independent of age, timing of MG manipulation, or baseline retinal condition and was not reproduced by preconditioning paradigms. Dicer-deficient MG displayed reduced glial fibrillary acidic protein (GFAP) immunoreactivity, indicating suppression of reactive gliosis; however, reduced GFAP alone was insufficient to confer neuroprotection. MG-specific miRNA depletion induces a neuroprotective retinal state characterized by preserved inner retinal function and reduced secondary degeneration. These results identify MG Dicer/miRNA networks as crucial regulators of injury responses and highlight not only a glia-driven degeneration mechanism but also a potential therapeutic target.

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

1
JCI Insight
241 papers in training set
Top 0.3%
7.2%
2
Glia
74 papers in training set
Top 0.1%
6.9%
3
Nature Communications
4913 papers in training set
Top 28%
6.4%
4
Journal of Neuroinflammation
50 papers in training set
Top 0.1%
6.4%
5
Investigative Opthalmology & Visual Science
37 papers in training set
Top 0.2%
4.9%
6
eLife
5422 papers in training set
Top 22%
4.0%
7
Aging Cell
144 papers in training set
Top 1%
3.6%
8
Cell Death & Disease
126 papers in training set
Top 0.3%
3.6%
9
Molecular Neurodegeneration
49 papers in training set
Top 0.2%
3.1%
10
Scientific Reports
3102 papers in training set
Top 41%
3.1%
11
Investigative Ophthalmology & Visual Science
22 papers in training set
Top 0.1%
2.9%
50% of probability mass above
12
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 24%
2.7%
13
eneuro
389 papers in training set
Top 4%
2.6%
14
Cell Reports
1338 papers in training set
Top 20%
2.4%
15
Experimental Neurology
57 papers in training set
Top 0.4%
2.4%
16
The Journal of Neuroscience
928 papers in training set
Top 5%
2.1%
17
Neurobiology of Disease
134 papers in training set
Top 3%
1.7%
18
The FASEB Journal
175 papers in training set
Top 1%
1.5%
19
PLOS ONE
4510 papers in training set
Top 56%
1.5%
20
Cell Reports Medicine
140 papers in training set
Top 5%
1.3%
21
Acta Neuropathologica Communications
81 papers in training set
Top 0.7%
1.3%
22
Molecular Therapy
71 papers in training set
Top 2%
1.2%
23
The American Journal of Pathology
31 papers in training set
Top 0.3%
1.0%
24
iScience
1063 papers in training set
Top 24%
1.0%
25
PLOS Genetics
756 papers in training set
Top 13%
0.9%
26
Human Molecular Genetics
130 papers in training set
Top 3%
0.8%
27
Frontiers in Cellular Neuroscience
79 papers in training set
Top 1%
0.8%
28
Developmental Cell
168 papers in training set
Top 12%
0.8%
29
EMBO Molecular Medicine
85 papers in training set
Top 5%
0.7%
30
Brain
154 papers in training set
Top 5%
0.7%